Tags

Type your tag names separated by a space and hit enter

Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus.
Vaccine. 1994 Nov; 12(15):1368-71.V

Abstract

Oral immunization of foxes by distributing vaccine baits was experimentally assessed and subsequently employed in the whole of the infected area of Belgium (10,000 km2). A vaccinia-rabies glycoprotein recombinant virus (VR-G) was used as vaccine because of its efficacy, safety and heat stability. Five 'full' campaigns of fox vaccination, carried out from 1989 until 1991, induced a drastic decrease in the incidence of rabies. The disease has disappeared from the major part of the initial infected area. In 1992 and 1993, three 'defence' campaigns, carried out along international borders, completely eliminated rabies virus infection from the fox population in 1993.

Authors+Show Affiliations

Department of Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, Belgium.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

7887012

Citation

Brochier, B, et al. "Towards Rabies Elimination in Belgium By Fox Vaccination Using a Vaccinia-rabies Glycoprotein Recombinant Virus." Vaccine, vol. 12, no. 15, 1994, pp. 1368-71.
Brochier B, Boulanger D, Costy F, et al. Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine. 1994;12(15):1368-71.
Brochier, B., Boulanger, D., Costy, F., & Pastoret, P. P. (1994). Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine, 12(15), 1368-71.
Brochier B, et al. Towards Rabies Elimination in Belgium By Fox Vaccination Using a Vaccinia-rabies Glycoprotein Recombinant Virus. Vaccine. 1994;12(15):1368-71. PubMed PMID: 7887012.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. AU - Brochier,B, AU - Boulanger,D, AU - Costy,F, AU - Pastoret,P P, PY - 1994/11/1/pubmed PY - 1994/11/1/medline PY - 1994/11/1/entrez SP - 1368 EP - 71 JF - Vaccine JO - Vaccine VL - 12 IS - 15 N2 - Oral immunization of foxes by distributing vaccine baits was experimentally assessed and subsequently employed in the whole of the infected area of Belgium (10,000 km2). A vaccinia-rabies glycoprotein recombinant virus (VR-G) was used as vaccine because of its efficacy, safety and heat stability. Five 'full' campaigns of fox vaccination, carried out from 1989 until 1991, induced a drastic decrease in the incidence of rabies. The disease has disappeared from the major part of the initial infected area. In 1992 and 1993, three 'defence' campaigns, carried out along international borders, completely eliminated rabies virus infection from the fox population in 1993. SN - 0264-410X UR - https://www.unboundmedicine.com/medline/citation/7887012/Towards_rabies_elimination_in_Belgium_by_fox_vaccination_using_a_vaccinia_rabies_glycoprotein_recombinant_virus_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0264-410X(94)90143-0 DB - PRIME DP - Unbound Medicine ER -